User menu

Arginase Structure and Inhibition: Catalytic Site Plasticity Reveals New Modulation Possibilities.

Bibliographic reference Mortier, Jérémie ; Prévost, Julien ; Sydow, Dominique ; Teuchert, Sabine ; Omieczynski, Christian ; et. al. Arginase Structure and Inhibition: Catalytic Site Plasticity Reveals New Modulation Possibilities.. In: Scientific Reports, Vol. 7, p. 13616 [1-9] (2017)
Permanent URL
  1. Rabinovich Gabriel A., Gabrilovich Dmitry, Sotomayor Eduardo M., Immunosuppressive Strategies that are Mediated by Tumor Cells, 10.1146/annurev.immunol.25.022106.141609
  2. Dolušić Eduard, Larrieu Pierre, Blanc Sébastien, Sapunaric Frédéric, Norberg Bernadette, Moineaux Laurence, Colette Delphine, Stroobant Vincent, Pilotte Luc, Colau Didier, Ferain Thierry, Fraser Graeme, Galeni Moreno, Frère Jean-Marie, Masereel Bernard, Van den Eynde Benoît, Wouters Johan, Frédérick Raphaël, Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors, 10.1016/j.bmc.2010.12.032
  3. Dolušić Eduard, Larrieu Pierre, Blanc Sébastien, Sapunaric Frédéric, Pouyez Jenny, Moineaux Laurence, Colette Delphine, Stroobant Vincent, Pilotte Luc, Colau Didier, Ferain Thierry, Fraser Graeme, Galleni Moreno, Frère Jean-Marie, Masereel Bernard, Van den Eynde Benoît, Wouters Johan, Frédérick Raphaël, Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors, 10.1016/j.ejmech.2011.02.049
  4. Dolušić Eduard, Larrieu Pierre, Moineaux Laurence, Stroobant Vincent, Pilotte Luc, Colau Didier, Pochet Lionel, Van den Eynde Benoît, Masereel Bernard, Wouters Johan, Frédérick Raphaël, Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators, 10.1021/jm2006782
  5. Pilotte L., Larrieu P., Stroobant V., Colau D., Dolusic E., Frederick R., De Plaen E., Uyttenhove C., Wouters J., Masereel B., Van den Eynde B. J., Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase, 10.1073/pnas.1113873109
  6. Rodríguez Paulo C., Ochoa Augusto C., Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives, 10.1111/j.1600-065x.2008.00608.x
  7. Morris Jr Sidney M, Recent advances in arginine metabolism: roles and regulation of the arginases, 10.1111/j.1476-5381.2009.00278.x
  8. Cama Evis, Shin Hyunshun, Christianson David W., Design of Amino Acid Sulfonamides as Transition-State Analogue Inhibitors of Arginase, 10.1021/ja036365b
  9. Zea Arnold H., Rodriguez Paulo C., Atkins Michael B., Hernandez Claudia, Signoretti Sabina, Zabaleta Jovanny, McDermott David, Quiceno David, Youmans Amanda, O'Neill Anne, Mier James, Ochoa Augusto C., Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasion, 10.1158/0008-5472.can-04-4505
  10. Singh, R., Pervin, S., Karimi, A., Cederbaum, S. & Chaudhuri, G. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 60, 3305–3312 (2000).
  11. Ochoa A. C., Zea A. H., Hernandez C., Rodriguez P. C., Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma, 10.1158/1078-0432.ccr-06-2197
  12. Chang, C. I., Liao, J. C. & Kuo, L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61, 1100–1106 (2001).
  13. Grohmann Ursula, Bronte Vincenzo, Control of immune response by amino acid metabolism : Metabolic regulation of immune responses, 10.1111/j.1600-065x.2010.00915.x
  14. Zimmermann Nives, Rothenberg Marc E., The arginine–arginase balance in asthma and lung inflammation, 10.1016/j.ejphar.2005.12.047
  15. Munder Markus, Role of arginase in asthma: potential clinical applications, 10.1586/ecp.09.53
  16. Munder Markus, Arginase: an emerging key player in the mammalian immune system : Arginase in the immune system, 10.1111/j.1476-5381.2009.00291.x
  17. Meurs Herman, Maarsingh Harm, Zaagsma Johan, Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness, 10.1016/s0165-6147(03)00227-x
  18. Kim Noel N., Cox J. David, Baggio Ricky F., Emig Frances A., Mistry Sanjay K., Harper Sandy L., Speicher David W., Morris, Sidney M., Ash David E., Traish Abdulmaged, Christianson David W., Probing Erectile Function: S-(2-Boronoethyl)-l-Cysteine Binds to Arginase as a Transition State Analogue and Enhances Smooth Muscle Relaxation in Human Penile Corpus Cavernosum†,‡, 10.1021/bi002317h
  19. Christianson David W., Cox J. David, Kim Noel N., Traish Abdulmaged M., 10.1038/14929
  20. Cama Evis, Colleluori Diana M., Emig Frances A., Shin Hyunshun, Kim Soo Woong, Kim Noel N., Traish Abdulmaged M., Ash David E., Christianson David W., Human Arginase II:  Crystal Structure and Physiological Role in Male and Female Sexual Arousal†,‡, 10.1021/bi034340j
  21. Bivalacqua Trinity J., Hellstrom Wayne J.G., Kadowitz Philip J., Champion Hunter C., Increased Expression of Arginase II in Human Diabetic Corpus Cavernosum: In Diabetic-Associated Erectile Dysfunction, 10.1006/bbrc.2001.4874
  22. Bivalacqua Trinity J., Burnett Arthur L., Hellstrom Wayne J. G., Champion Hunter C., Overexpression of arginase in the aged mouse penis impairs erectile function and decreases eNOS activity: influence of in vivo gene therapy of anti-arginase, 10.1152/ajpheart.00121.2005
  23. Grasemann Hartmut, Schwiertz Raphael, Matthiesen Sonja, Racké Kurt, Ratjen Felix, Increased Arginase Activity in Cystic Fibrosis Airways, 10.1164/rccm.200502-253oc
  24. Yang Zhihong, Ming Xiu-Fen, Endothelial arginase: A new target in atherosclerosis, 10.1007/s11906-006-0041-8
  25. Santhanam Lakshmi, Christianson David W., Nyhan Daniel, Berkowitz Dan E., Arginase and vascular aging, 10.1152/japplphysiol.90627.2008
  26. Ryoo S., Gupta G., Benjo A., Lim H. K., Camara A., Sikka G., Lim H. K., Sohi J., Santhanam L., Soucy K., Tuday E., Baraban E., Ilies M., Gerstenblith G., Nyhan D., Shoukas A., Christianson D. W., Alp N. J., Champion H. C., Huso D., Berkowitz D. E., Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis, 10.1161/circresaha.107.169573
  27. Nelin Leif D., Wang Xianxi, Zhao Qun, Chicoine Louis G., Young Tamara L., Hatch Dionna M., English B. Keith, Liu Yusen, MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge, 10.1152/ajpcell.00137.2006
  28. Di Costanzo Luigi, Pique Michael E., Christianson David W., Crystal Structure of Human Arginase I Complexed with Thiosemicarbazide Reveals an Unusual Thiocarbonyl μ-Sulfide Ligand in the Binuclear Manganese Cluster, 10.1021/ja071567j
  29. Ilies Monica, Di Costanzo Luigi, Dowling Daniel P., Thorn Katherine J., Christianson David W., Binding of α,α-Disubstituted Amino Acids to Arginase Suggests New Avenues for Inhibitor Design, 10.1021/jm200443b
  30. Ilies Monica, Di Costanzo Luigi, North Michelle L., Scott Jeremy A., Christianson David W., 2-Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme Human Arginase I, 10.1021/jm100306a
  31. Di Costanzo Luigi, Ilies Monica, Thorn Katherine J., Christianson David W., Inhibition of human arginase I by substrate and product analogues, 10.1016/
  32. Boucher J.L., Custot J., Vadon S., Delaforge M., Lepoivre M., Tenu J.P., Yapo A., Mansuy D., Nω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, Is a Strong Inhibitor of Liver and Macrophage Arginase, 10.1006/bbrc.1994.2371
  33. Kotthaus Jürke, Schade Dennis, Töpker-Lehmann Katrin, Beitz Eric, Clement Bernd, Nδ-Methylated l-arginine derivatives and their effects on the nitric oxide generating system, 10.1016/j.bmc.2007.11.066
  34. Di Costanzo L., Sabio G., Mora A., Rodriguez P. C., Ochoa A. C., Centeno F., Christianson D. W., Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response, 10.1073/pnas.0504027102
  35. Pudlo Marc, Demougeot Céline, Girard-Thernier Corine, Arginase Inhibitors: A Rational Approach Over One Century : AN EXHAUSTIVE REVIEW OF ARGINASE INHIBITORS, 10.1002/med.21419
  36. Rüegg Urs T., Russell Anthony S., A rapid and sensitive assay for arginase, 10.1016/0003-2697(80)90340-1
  37. Murgueitio Manuela S., Bermudez Marcel, Mortier Jérémie, Wolber Gerhard, In silico virtual screening approaches for anti-viral drug discovery, 10.1016/j.ddtec.2012.07.009
  38. Cadicamo Cosimo D., Mortier Jérémie, Wolber Gerhard, Hell Marie, Heinrich Ina E., Michel Dana, Semlin Lydia, Berger Ursula, Korting Hans C., Höltje Hans-Dieter, Koksch Beate, Borelli Claudia, Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans, 10.1016/j.bcp.2012.12.008
  39. Asante Vivian, Mortier Jérémie, Wolber Gerhard, Koksch Beate, Impact of fluorination on proteolytic stability of peptides: a case study with α-chymotrypsin and pepsin, 10.1007/s00726-014-1819-7
  40. Al-Asri Jamil, Gyémánt Gyöngyi, Fazekas Erika, Lehoczki Gábor, Melzig Matthias F., Wolber Gerhard, Mortier Jérémie, α-Amylase Modulation: Discovery of Inhibitors Using a Multi-Pharmacophore Approach for Virtual Screening, 10.1002/cmdc.201600427
  41. Al-Asri Jamil, Fazekas Erika, Lehoczki Gábor, Perdih Andrej, Görick Cornelia, Melzig Matthias F., Gyémánt Gyöngyi, Wolber Gerhard, Mortier Jérémie, From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors, 10.1016/j.bmc.2015.09.007
  42. Mortier Jérémie, Masereel Bernard, Remouchamps Caroline, Ganeff Corinne, Piette Jacques, frederick Raphaël, NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening, 10.1016/j.bmcl.2010.06.027
  43. Mortier Jérémie, Frederick Raphaël, Ganeff Corinne, Remouchamps Caroline, Talaga Patrice, Pochet Lionel, Wouters Johan, Piette Jacques, Dejardin Emmanuel, Masereel Bernard, Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-κB activation, 10.1016/j.bcp.2010.01.007
  44. Ottanà Rosaria, Maccari Rosanna, Mortier Jérémie, Caselli Anna, Amuso Simona, Camici Guido, Rotondo Archimede, Wolber Gerhard, Paoli Paolo, Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells, 10.1016/j.ejmech.2013.11.001
  45. Bermudez Marcel, Mortier Jeremie, Rakers Christin, Sydow Dominique, Wolber Gerhard, More than a look into a crystal ball: protein structure elucidation guided by molecular dynamics simulations, 10.1016/j.drudis.2016.07.001
  46. Mortier Jérémie, Rakers Christin, Bermudez Marcel, Murgueitio Manuela S., Riniker Sereina, Wolber Gerhard, The impact of molecular dynamics on drug design: applications for the characterization of ligand–macromolecule complexes, 10.1016/j.drudis.2015.01.003
  47. Rakers Christin, Bermudez Marcel, Keller Bettina G., Mortier Jérémie, Wolber Gerhard, Computational close up on protein-protein interactions: how to unravel the invisible using molecular dynamics simulations? : Computational close up on protein-protein interactions, 10.1002/wcms.1222
  48. Boonstra Sander, Onck Patrick R., van der Giessen Erik, CHARMM TIP3P Water Model Suppresses Peptide Folding by Solvating the Unfolded State, 10.1021/acs.jpcb.6b01316
  49. Bowers, K. J. et al. In ACM/IEEE conference on Supercomputing. 746 (ACM).
  50. Kaminski George A., Friesner Richard A., Tirado-Rives Julian, Jorgensen William L., Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides†, 10.1021/jp003919d
  51. Durrant Jacob D., Votapka Lane, Sørensen Jesper, Amaro Rommie E., POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics, 10.1021/ct500381c
  52. Mortier Jeremie, Rakers Christin, Frederick Raphael, Wolber Gerhard, Computational Tools for In Silico Fragment-Based Drug Design, 10.2174/156802612804547371
  53. Bock Andreas, Bermudez Marcel, Krebs Fabian, Matera Carlo, Chirinda Brian, Sydow Dominique, Dallanoce Clelia, Holzgrabe Ulrike, De Amici Marco, Lohse Martin J., Wolber Gerhard, Mohr Klaus, Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor, 10.1074/jbc.m116.735431
  54. Nizami Bilal, Sydow Dominique, Wolber Gerhard, Honarparvar Bahareh, Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis, 10.1039/c6mb00428h
  55. Martyna Glenn J., Tobias Douglas J., Klein Michael L., Constant pressure molecular dynamics algorithms, 10.1063/1.467468
  56. Nosé Shūichi, An extension of the canonical ensemble molecular dynamics method, 10.1080/00268978600100141
  57. Hoover William G., Canonical dynamics: Equilibrium phase-space distributions, 10.1103/physreva.31.1695
  58. Abraham Mark James, Murtola Teemu, Schulz Roland, Páll Szilárd, Smith Jeremy C., Hess Berk, Lindahl Erik, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, 10.1016/j.softx.2015.06.001
  59. Lindorff-Larsen Kresten, Piana Stefano, Palmo Kim, Maragakis Paul, Klepeis John L., Dror Ron O., Shaw David E., Improved side-chain torsion potentials for the Amber ff99SB protein force field, 10.1002/prot.22711
  60. Wang Junmei, Wolf Romain M., Caldwell James W., Kollman Peter A., Case David A., Development and testing of a general amber force field, 10.1002/jcc.20035
  61. Sousa da Silva Alan W, Vranken Wim F, ACPYPE - AnteChamber PYthon Parser interfacE, 10.1186/1756-0500-5-367
  62. Hess Berk, Bekker Henk, Berendsen Herman J. C., Fraaije Johannes G. E. M., LINCS: A linear constraint solver for molecular simulations, 10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>;2-h
  63. Parrinello, M. & Rahman, A. A Molecular-Dynamics Study of Crystal-Structure Transformations. B Am Phys Soc 26, 380–380 (1981).
  64. Wolber Gerhard, Langer Thierry, LigandScout:  3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters, 10.1021/ci049885e